RESIDUAL TUMOR (R) CLASSIFICATION AND PROGNOSIS

被引:133
作者
HERMANEK, P
WITTEKIND, C
机构
[1] Departments of Surgery, University of Erlangen, Erlangen
[2] Departments of Pathology, University of Erlangen, Erlangen
来源
SEMINARS IN SURGICAL ONCOLOGY | 1994年 / 10卷 / 01期
关键词
COLORECTAL CARCINOMA; GASTRIC CARCINOMA; LIVER METASTASES; LUNG METASTASES; NONSMALL CELL CARCINOMA OF LUNG; R-CLASSIFICATION;
D O I
10.1002/ssu.2980100105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor status following treatment is described by the residual tumor (R) classification: R0, no residual tumor; R1, microscopic residual tumor; R2, macroscopic residual tumor. Residual tumor may be found in the area of primary tumor and its regional lymph nodes and/or at distant sites. The R classification reflects the effects of treatment and influences further treatment planning. Furthermore, the R classification is a strong predictor of prognosis. An acceptable long-term prognosis can be expected only in R0 patients. Although there exist clear correlations between stage and R classification the differences in prognosis of R0 versus R1,2 cannot be explained by differences in stage alone. The prognostic significance of R classification is demonstrated by respective data for non-small cell lung carcinoma, squamous cell carcinoma of oesophagus, gastric carcinoma, ductal adenocarcinoma of the pancreas, colorectal carcinoma, lung and liver metastases. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:12 / 20
页数:9
相关论文
共 38 条
[11]  
UICC and Japanese stage classification for carcinoma of the pancreas, Int J Pancreatol, 8, pp. 205-214, (1991)
[12]  
The General Rules for Gastric Cancer Study, (1993)
[13]  
Hermanek P, Wittekind C, (1993)
[14]  
Chapuis, Dent OF, Fisher R, Et al., A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer, Br J Surg, 72, pp. 698-702, (1985)
[15]  
Kampschoer GMH, Maruyama K, Sasako M, Et al., The effects of blood transfusion on the prognosis of patients with gastric cancer, World Journal of Surgery, 13, pp. 637-643, (1989)
[16]  
Jaehne J, Meyer HJ, Maschek H, Et al., Lymphadenectomy in gastric carcinoma—a prospective and prognostic study, Arch Surg, 127, pp. 290-294, (1992)
[17]  
Roder JD, Bottcher K, Siewert JR, Et al., Prognostic factors in gastric carcinoma: results of the German Gastric Carcinoma Study 1992, Cancer, 72, pp. 2089-2097, (1993)
[18]  
Hermanek P, Liver metastasis: classification and staging systems, Eur Clin Dig Dis Suppl Series, 1, pp. 15-22, (1992)
[19]  
Veronesi U, Farante G, Galimberti V, Et al., Evaluation of resection margins after breast conservative surgery with monoclonal antibodies, Eur J Surg Oncol, 17, pp. 338-341, (1991)
[20]  
Nakajima T, Harashima S, Hirata M, Et al., Prognostic and therapeutic values of peritoneal cytology in gastric cancer, Acta Cytol, 22, pp. 225-229, (1978)